Fig. 3. (A) The event-free survival (EFS) and (B) overall survival (OS). Patients with iAMP21 were likely to have worse survival rates although there was no statistical significance. The intersection of survival curve of each group was observed at around 5 years after diagnosis in EFS and OS.